Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical Practice

Clinical trial NCT07663786 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07663786
Sponsor: Bristol-Myers Squibb
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Esophageal Adenocarcinoma Gastro-esophageal Junction Adenocarcinoma Gastric Adenocarcinoma

Start date: 2025-10-09
Primary completion: 2026-10-01
Enrollment: 726

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.